Show simple item record

dc.contributor.authorBartunek, Jozef
dc.contributor.authorTerzic, Andre
dc.contributor.authorBehfar, Atta
dc.contributor.authorWijns, William
dc.date.accessioned2018-09-20T16:00:38Z
dc.date.available2018-09-20T16:00:38Z
dc.date.issued2018-05-10
dc.identifier.citationBartunek, Jozef; Terzic, Andre; Behfar, Atta; Wijns, William (2018). Clinical experience with regenerative therapy in heart failure. Circulation Research 122 (10), 1344-1346
dc.identifier.issn0009-7330,1524-4571
dc.identifier.urihttp://hdl.handle.net/10379/10369
dc.description.abstractAdoption of regenerative strategies for heart failure is challenged by mixed outcomes in clinical trials. Ongoing development plans strive to improve biotherapeutic potency, optimize delivery, standardize dosing, and target responsive patient populations. The CHART (Congestive Heart Failure Cardiopoietic Regenerative Therapy) program offers advanced experience in clinical development of next-generation regenerative therapies.
dc.publisherOvid Technologies (Wolters Kluwer Health)
dc.relation.ispartofCirculation Research
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Ireland
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/3.0/ie/
dc.subjectheart
dc.subjectheart failure
dc.subjectmyocardial infarction
dc.subjectphenotype
dc.subjectstandard of care
dc.subjectdouble-blind
dc.subjectchart-1
dc.subjecttrial
dc.subjectinfarction
dc.subjectbenefit
dc.subjectrepair
dc.titleClinical experience with regenerative therapy in heart failure
dc.typeArticle
dc.identifier.doi10.1161/circresaha.118.312753
dc.local.publishedsourcehttp://circres.ahajournals.org/content/122/10/1344.full.pdf
nui.item.downloads0


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Ireland
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Ireland